Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institutes of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, ZDK1 GRB-4(J1).
Date: November 19-21, 2001.
Time: 7:30 p.m. to 11 a.m.
Agenda: To review and evaluate grant applications.
Place: Houston Marriott Medical Center, 6580 Fannin St., Houston, TX 77030.
Contact Person: John Connaughton, PhD, Scientific Review Administrator, Review Branch, DEA, NIDDK, Room 757, 6707 Democracy Boulevard, National Institutes of Health, Bethesda, MD 20892, (301) 594-7797, firstname.lastname@example.org.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)Start Signature
Dated: October 26, 2001.
LaVerne J. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-27508 Filed 11-1-01; 8:45 am]
BILLING CODE 4140-1-M